Literature DB >> 3741871

Developmental control of gene expression of tryptophan 2,3-dioxygenase in neonatal rat liver.

M Nagao, T Nakamura, A Ichihara.   

Abstract

The developmental change in gene expression of tryptophan 2,3-dioxygenase (EC 1.13.11.11) in rat liver was studied by dot-blot hybridization with cDNA of the enzyme as a probe. The mRNA of tryptophan oxygenase is not expressed in fetal liver, but is expressed very slightly 1 day after birth. Its expression increases first gradually until 12 days after birth and then rapidly, and reaches the adult level about 22 days after birth. On the other hand, mRNA of albumin in the liver, measured with its cDNA, increases rapidly in the late fetal period and reaches almost the adult level at the time of birth. Studies on in vitro transcription by the nuclear run-off technique showed that the developmental increases in the mRNAs of tryptophan oxygenase and albumin are caused by an increase in the rates of transcription of their genes. Treatment of rats with cortisol significantly increased the amount of tryptophan oxygenase mRNA in the liver from soon after birth. This treatment did not increase mRNA of albumin. It is suggested from these findings that the gene of tryptophan oxygenase is switched on as early as the first day after birth in the few differentiated hepatocytes present in the liver and that the number of these differentiated cells gradually increases during early postnatal development. Although injected glucocorticoid stimulated transcription of the gene of tryptophan oxygenase precociously during this period, presumably in vivo the activity of tryptophan oxygenase normally increases about 2 weeks after birth, because this is when the plasma concentrations of glucocorticoid and glucagon increase sufficiently to be effective.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3741871     DOI: 10.1016/0167-4781(86)90032-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.

Authors:  A Kamiya; T Kinoshita; Y Ito; T Matsui; Y Morikawa; E Senba; K Nakashima; T Taga; K Yoshida; T Kishimoto; A Miyajima
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

2.  Functional proteomic analysis of corticosteroid pharmacodynamics in rat liver: Relationship to hepatic stress, signaling, energy regulation, and drug metabolism.

Authors:  Vivaswath S Ayyar; Richard R Almon; Debra C DuBois; Siddharth Sukumaran; Jun Qu; William J Jusko
Journal:  J Proteomics       Date:  2017-03-14       Impact factor: 4.044

3.  Partial blockage of hepatocyte maturation in hepatoma-derived growth factor transgenic mice.

Authors:  Hirayuki Enomoto; Hideji Nakamura; Naoko Komatsu-Kanatani; Yu Liu; Kenya Yoshida; Yorihide Okuda; Teruhisa Yamamoto; Weidong Liu; Shuhei Nishiguchi
Journal:  World J Hepatol       Date:  2009-10-31

4.  Pre-translational control of hepatic malic enzyme expression during the development of the rat.

Authors:  D J Mann; E Bailey
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

5.  Liver-enriched transcription factors are critical for the expression of hepatocyte marker genes in mES-derived hepatocyte-lineage cells.

Authors:  Pakpoom Kheolamai; Alan J Dickson
Journal:  BMC Mol Biol       Date:  2009-04-23       Impact factor: 2.946

Review 6.  Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery.

Authors:  Jennifer L Remus; Robert Dantzer
Journal:  Int J Neuropsychopharmacol       Date:  2016-09-21       Impact factor: 5.176

7.  Extensive Epigenetic Changes Accompany Terminal Differentiation of Mouse Hepatocytes After Birth.

Authors:  Matthew V Cannon; Genay Pilarowski; Xiuli Liu; David Serre
Journal:  G3 (Bethesda)       Date:  2016-11-08       Impact factor: 3.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.